<DOC>
	<DOCNO>NCT02617771</DOCNO>
	<brief_summary>Up date , clinical trial evaluate efficacy safety Vitamin D supplementation child RRI , conclusive information . Therefore , design prospective , single-blind , clinical trial evaluate whether oral supplementation vitamin D October April reduce global health burden recurrent respiratory tract infection primary care set . The primary outcome evaluate Vitamin D supplementation autumn winter reduce number respiratory tract infection child diagnose recurrent respiratory tract infection season . Secondary objective assessment Vitamin D supplementation benefit global socioeconomic burden recurrent respiratory tract infection primary care setting , accord number visit primary care paediatrician use antibiotic due respiratory tract infection .</brief_summary>
	<brief_title>Impact Vitamin D Supplementation Recurrent Respiratory Infections Paediatric Primary Care .</brief_title>
	<detailed_description>The University study personnel randomly allocate patient receive , October March , Vitamin D oral supplementation ( 400 UI/die 12 month 600 UI/die beyond 1 year ) . Randomization perform use free web-based service offer random assignment ; patient randomize consider gender age class ( 12 month ; beyond 1 year ) . The primary care practitioner blind regard study group allocation . Inclusion criterion : ) patient diagnosed season : ≥ 6 respiratory infection per annum OR ≥ 1 respiratory infection per month involve upper airway September April OR ≥ 3 respiratory infection per annum involve low airway . b ) patient finding suggestive immunodeficiency history physical examination . From recruitment , parent record number type diagnose respiratory tract infection , number ambulatory visit , use antibiotic duration symptom structure diary . Upper Respiratory Tract Infections ( URTIs ) comprehend diagnosis acute otitis medium , acute rhinosinusitis acute pharyngotonsillitis . Lower Respiratory Tract Infections ( LRTIs ) comprehend diagnosis bronchiolitis pneumonia . All parent close telephone contact help diary compilation . Adverse event relate protocol monitor . Missing data recover information system primary care practitioner . Quantitative data express mean standard deviation . To compare mean two group , Student 's t-test unpaired use . The frequency visit pediatrician use antibiotic two group calculate express percentage . The χ² test use compare percentages two group . For test , P-values &lt; 0.05 consider significant . Since Italian National Health System cover cost pediatrician visit antibiotic , cost assessment make analyse cost regard frequency parameter treat nontreated group . We consider direct cost National Health System : Medical examination ( 20,66 euro examination , provide Italian Ministry Health ) use Antibiotics ( cost list National Drug Authority ) .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>patient diagnose season : ≥ 6 respiratory infection per annum ≥ 1 respiratory infection per month involve upper airway September April ≥ 3 respiratory infection per annum involve low airway patient finding suggestive immunodeficiency history physical examination</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>